NATCO PHARMA LTD. vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of NATCO PHARMA LTD. (NATCOPHARM) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

NATCO PHARMA LTD. and ZYDUS LIFESCIENCES LTD are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

11.93
P/E ratio
22.83
1.81
P/B ratio
4.09
0.52%
Dividend yield
0.09%
₹79.20
EPS
₹50.09

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.90%
Return on equity
21.20%
17.00%
Return on capital
21.00%
35.00%
EBITDA margin
31.00%
34.77%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.64%
Revenue CAGR (3Y)
16.35%
25.64%
Profit CAGR (3Y)
34.80%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹16,932 Cr
Market cap
₹1.15L Cr
₹4,078 Cr
Revenue
₹27,148 Cr
₹1,418 Cr
Net profit
₹5,124 Cr
0.08
Debt / equity
0.46
NATCO PHARMA LTD.
  • + ["Company is almost debt free.", "Company has delivered good profit growth of 27.7% CAGR over last 5 years"]
  • ["Tax rate seems low"]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
NATCO PHARMA LTD. full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

NATCO PHARMA LTD. vs ZYDUS LIFESCIENCES LTD: Share Price, Valuation & Which to Buy | DocStoX